Furanonaphthoquinones, Diterpenes, and Flavonoids from Sweet Marjoram and Investigation of Antimicrobial, Bacterial Efflux, and Biofilm Formation Inhibitory Activities.
Tasneem Sultan Abu GhazalKatalin VeresLívia VidácsNikoletta SzemerédiGabriella SpenglerRóbert BerkeczJudit HohmannPublished in: ACS omega (2023)
The chloroform extract of Origanum majorana exhibited high antibacterial and antifungal activities against 12 bacterial and 4 fungal strains; therefore, it was subjected to bioassay-guided isolation to afford six compounds ( 1 - 6 ). The structures were determined via one- and two-dimensional nuclear magnetic spectroscopy and high-resolution electrospray ionization mass spectrometry experiments. The compounds were identified as furanonaphthoquinones [majoranaquinone ( 1 ), 2,3-dimethylnaphtho[2,3- b ]furan-4,9-dione ( 2 )], diterpenes [19-hydroxyabieta-8,11,13-trien-7-one ( 3 ), 13,14-seco-13-oxo-19-hydroxyabieta-8-en-14-al ( 4 )], and flavonoids [sterubin ( 5 ) and majoranin ( 6 )]. Compounds 1 and 2 were first obtained from a natural source and compounds 3 and 4 were previously undescribed. Majoranaquinone ( 1 ) exhibited a high antibacterial effect against 4 Staphylococcus , 1 Moraxella , and 1 Enterococcus strains (MIC values between 7.8 μM and 1 mM). In the efflux pump inhibition assay, majoranaquinone ( 1 ) showed substantial activity in Escherichia coli ATCC 25922 strain. Furthermore, 1 was found to be an effective biofilm formation inhibitor on E. coli ATCC 25922 and E. coli K-12 AG100 bacteria. Our findings proved that bioactivities of majoranaquinone ( 1 ) significantly exceed those of the essential oil constituents; therefore, it should also be considered when assessing the antimicrobial effects of O. majorana .
Keyphrases
- biofilm formation
- escherichia coli
- essential oil
- high resolution
- staphylococcus aureus
- candida albicans
- mass spectrometry
- pseudomonas aeruginosa
- klebsiella pneumoniae
- oxidative stress
- single molecule
- anti inflammatory
- quantum dots
- liquid chromatography
- cystic fibrosis
- high performance liquid chromatography
- ms ms
- highly efficient
- multidrug resistant
- solid state
- single cell